Wong SH

ORCID: 0000-0002-3354-9310 · 4 papers in corpus
2026
Recommendations for implementing patient blood management—an updated modified Delphi consensus from a multidisciplinary expert panel in Hong Kong
Journal of anesthesia, analgesia and critical care ·doi:10.1186/s44158-026-00417-4

In 2020, the Hong Kong Society of Clinical Blood Management (HKSCBM) established a consensus statement on the implementation of patient blood management (PBM). Based on recent evidence on PBM initiatives and practices, the HKSCBM updated th…

2025
Transmission of antimicrobial resistance genes from the environment to human gut is more pronounced in colorectal cancer patients than in healthy subjects.
iMeta ·doi:10.1002/imt2.70008

Antimicrobial resistance is a major global health concern. However, the source of gut resistome remains unsolved. We aimed to analyze the contribution of environmental antimicrobial resistance genes (ARGs) to colorectal cancer (CRC) patient…

2021
Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects.
Journal of gastroenterology and hepatology ·doi:10.1111/jgh.15171

Background and aimWe have previously shown that fecal microbial markers might be useful for non-invasive diagnosis of colorectal cancer (CRC) and adenoma. Here, we assessed the application of microbial DNA markers, as compared with and in c…

2020
A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer.
Gut ·doi:10.1136/gutjnl-2019-318532

ObjectiveThere is a need for early detection of colorectal cancer (CRC) at precancerous-stage adenoma. Here, we identified novel faecal bacterial markers for diagnosing adenoma.DesignThis study included 1012 subjects (274 CRC, 353 adenoma a…